149 related articles for article (PubMed ID: 18344376)
1. Estrogen, nitric oxide, and hypertension differentially modulate agonist-induced contractile responses in female transgenic (mRen2)27 hypertensive rats.
Brosnihan KB; Li P; Figueroa JP; Ganten D; Ferrario CM
Am J Physiol Heart Circ Physiol; 2008 May; 294(5):H1995-2001. PubMed ID: 18344376
[TBL] [Abstract][Full Text] [Related]
2. Exercise training attenuates angiotensin II-induced vasoconstriction in the aorta of normotensive but not hypertensive rats.
Oliveira PR; Oliveira PB; Rossignoli PS; Spadella MA; Chies AB
Exp Physiol; 2020 Apr; 105(4):732-742. PubMed ID: 31999028
[TBL] [Abstract][Full Text] [Related]
3. Estrogen protects transgenic hypertensive rats by shifting the vasoconstrictor-vasodilator balance of RAS.
Brosnihan KB; Li P; Ganten D; Ferrario CM
Am J Physiol; 1997 Dec; 273(6):R1908-15. PubMed ID: 9435644
[TBL] [Abstract][Full Text] [Related]
4. Chronic estrogen treatment in female transgenic (mRen2)27 hypertensive rats augments endothelium-derived nitric oxide release.
Li P; Ferrario CM; Ganten D; Brosnihan KB
Am J Hypertens; 1997 Jun; 10(6):662-70. PubMed ID: 9194513
[TBL] [Abstract][Full Text] [Related]
5. Estrogen receptor-mediated enhancement of venous relaxation in female rat: implications in sex-related differences in varicose veins.
Raffetto JD; Qiao X; Beauregard KG; Khalil RA
J Vasc Surg; 2010 Apr; 51(4):972-81. PubMed ID: 20347696
[TBL] [Abstract][Full Text] [Related]
6. [Role of nitric oxide in the modulation of the vascular response to angiotensin II in hypertensive rats].
Sánchez Mendoza A; Vázquez Cruz B; Escalante Acosta BA
Arch Inst Cardiol Mex; 1996; 66(4):306-12. PubMed ID: 8984951
[TBL] [Abstract][Full Text] [Related]
7. Enhanced AT1 receptor-mediated vasocontractile response to ANG II in endothelium-denuded aorta of obese Zucker rats.
Siddiqui AH; Hussain T
Am J Physiol Heart Circ Physiol; 2007 Apr; 292(4):H1722-7. PubMed ID: 17142345
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial arginase II constrains endothelial NOS-3 activity.
Lim HK; Lim HK; Ryoo S; Benjo A; Shuleri K; Miriel V; Baraban E; Camara A; Soucy K; Nyhan D; Shoukas A; Berkowitz DE
Am J Physiol Heart Circ Physiol; 2007 Dec; 293(6):H3317-24. PubMed ID: 17827260
[TBL] [Abstract][Full Text] [Related]
9. Endothelial dysfunction in the aorta of transgenic rats harboring the mouse Ren-2 gene.
Arnet UA; Novosel D; Barton M; Noll G; Ganten D; Lüscher TF
Endothelium; 1999; 6(3):175-84. PubMed ID: 10365769
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide production contributes to Bacillus anthracis edema toxin-associated arterial hypotension and lethality: ex vivo and in vivo studies in the rat.
Li Y; Cui X; Xu W; Ohanjanian L; Sampath-Kumar H; Suffredini D; Moayeri M; Leppla S; Fitz Y; Eichacker PQ
Am J Physiol Heart Circ Physiol; 2016 Sep; 311(3):H781-93. PubMed ID: 27448553
[TBL] [Abstract][Full Text] [Related]
11. Tempol selectively attenuates angiotensin II evoked vasoconstrictor responses in spontaneously hypertensive rats.
Shastri S; Gopalakrishnan V; Poduri R; Di Wang H
J Hypertens; 2002 Jul; 20(7):1381-91. PubMed ID: 12131535
[TBL] [Abstract][Full Text] [Related]
12. Increased vascular angiotensin type 2 receptor expression and NOS-mediated mechanisms of vascular relaxation in pregnant rats.
Stennett AK; Qiao X; Falone AE; Koledova VV; Khalil RA
Am J Physiol Heart Circ Physiol; 2009 Mar; 296(3):H745-55. PubMed ID: 19151255
[TBL] [Abstract][Full Text] [Related]
13. Failure of L-nitroarginine to inhibit the activity of aortic inducible nitric oxide synthase.
Darblade B; Batkai S; Caussé E; Gourdy P; Fouque MJ; Rami J; Arnal JF
J Vasc Res; 2001; 38(3):266-75. PubMed ID: 11399899
[TBL] [Abstract][Full Text] [Related]
14. The inhibitory effect of leptin on angiotensin II-induced vasoconstriction in vascular smooth muscle cells is mediated via a nitric oxide-dependent mechanism.
Rodríguez A; Fortuño A; Gómez-Ambrosi J; Zalba G; Díez J; Frühbeck G
Endocrinology; 2007 Jan; 148(1):324-31. PubMed ID: 17038553
[TBL] [Abstract][Full Text] [Related]
15. Effects of pioglitazone and rosiglitazone on aortic vascular function in rat genetic hypertension.
Llorens S; Mendizabal Y; Nava E
Eur J Pharmacol; 2007 Dec; 575(1-3):105-12. PubMed ID: 17803988
[TBL] [Abstract][Full Text] [Related]
16. Phenylephrine activates eNOS Ser 1177 phosphorylation and nitric oxide signaling in renal hypertensive rat aorta.
Silva BR; Pernomian L; Grando MD; Bendhack LM
Eur J Pharmacol; 2014 Sep; 738():192-9. PubMed ID: 24886887
[TBL] [Abstract][Full Text] [Related]
17. Deletion of inducible nitric oxide synthase decreases mesenteric vascular responsiveness in portal hypertensive mice.
Bexis S; Vandeputte C; McCormick PA; Docherty JR
Eur J Pharmacol; 2004 Sep; 499(3):325-33. PubMed ID: 15381055
[TBL] [Abstract][Full Text] [Related]
18. Endothelial nitric oxide synthase is predominantly involved in angiotensin II modulation of renal vascular resistance and norepinephrine release.
Stegbauer J; Kuczka Y; Vonend O; Quack I; Sellin L; Patzak A; Steege A; Langnaese K; Rump LC
Am J Physiol Regul Integr Comp Physiol; 2008 Feb; 294(2):R421-8. PubMed ID: 18046021
[TBL] [Abstract][Full Text] [Related]
19. Association of testosterone with estrogen abolishes the beneficial effects of estrogen treatment by increasing ROS generation in aorta endothelial cells.
Costa TJ; Ceravolo GS; dos Santos RA; de Oliveira MA; Araújo PX; Giaquinto LR; Tostes RC; Akamine EH; Fortes ZB; Dantas AP; Carvalho MH
Am J Physiol Heart Circ Physiol; 2015 Apr; 308(7):H723-32. PubMed ID: 25637546
[TBL] [Abstract][Full Text] [Related]
20. Interactions of adenosine A1 receptor-mediated renal vasoconstriction with endogenous nitric oxide and ANG II.
Barrett RJ; Droppleman DA
Am J Physiol; 1993 Nov; 265(5 Pt 2):F651-9. PubMed ID: 8238545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
